meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis

Clinical trial NCT05715814 · RECRUITING

Trial details

NCT number: NCT05715814
Sponsor: University Health Network, Toronto
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Peritoneal Dialysis Complication End Stage Kidney Disease Sodium-glucose Co-transporter-2 Inhibitors Kidney Dysfunction Residual Kidney Function

Start date: 2024-09-01
Primary completion: 2027-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.